早期血运重建后急性缺血性卒中病灶ADC快速演变
这项回顾性研究纳入50例前循环急性缺血性卒中患者,比较血管内治疗(EVT)联合或不联合静脉tPA与仅静脉tPA对核心梗死区ADC演变的影响。结果显示,血运重建患者24小时ADC值显著升高、核心逆转率更高(69% vs 22%,P=0.002),90天良好临床结局比例更高(63% vs 9%,P=0.003)。
要点
- 早期完全血运重建可致急性缺血性卒中核心病灶ADC值24小时内快速正常化。
- 血运重建患者24小时核心逆转率显著高于未血运重建者(69% vs 22%,P=0.002)。
- 血运重建与90天良好临床结局独立相关(63% vs 9%,P=0.003)。
核心结论
- 早期完全血运重建后ADC演变与历史认识显著不同,可能包含继发性损伤成分。
- ADC正常化或可作为未来辅助治疗的潜在影像生物标志物。
研究设计与样本
- 回顾性研究纳入2015至2017年接受EVT联合或不联合IVT的前循环急性缺血性卒中患者,与2015年前连续IVT-only队列比较。
- 共50例患者,25例(50%)接受IVT,25例(50%)接受EVT联合或不联合IVT。
主要发现
- 血运重建患者24小时核心病灶ADC中位值显著升高,而未血运重建患者ADC进一步降低。
- 血运重建患者90天良好临床结局(mRS 0-2)比例为63%,未血运重建者为9%(P=0.003)。
- 血运重建患者24小时核心逆转率为69%,未血运重建者为22%(P=0.002)。
- 两组在年龄、性别、基线NIHSS、院间转运或IVT率方面无差异。
关键数值与推荐
- 良好临床结局定义为90天改良Rankin量表评分0至2分。
- 基线核心病灶通过弥散加权成像(DWI)和ADC图量化。
- 24小时评估ADC中位值变化和核心逆转,24小时和5天评估DWI病灶增长。
临床怎么用
- EVT术后早期ADC快速正常化应结合临床综合判断,不宜简单视为良性恢复。
- ADC演变特征可能为未来辅助治疗试验提供影像学筛选依据。
局限性
- 回顾性设计,样本量较小(共50例)。
- 历史对照队列来自2015年前,存在时间偏倚可能。
- 未报告多变量校正分析结果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background and Purpose- In this era of endovascular therapy (EVT) with early, complete recanalization and reperfusion, we have observed an even more rapid apparent diffusion coefficient (ADC) normalization within the acute ischemic lesion compared with the natural history or IV-tPA-treated patient. In this study, we aimed to evaluate the effect of revascularization on ADC evolution within the core lesion in the first 24 hours in acute ischemic stroke patients. Methods- This retrospective study included anterior circulation acute ischemic stroke patients treated with EVT with or without intravenous tPA (IVT) from 2015 to 2017 compared with a consecutive cohort of IVT-only patients treated before 2015. Diffusion-weighted imaging and ADC maps were used to quantify baseline core lesions. Median ADC value change and core reversal were determined at 24 hours. Diffusion-weighted imaging lesion growth was measured at 24 hours and 5 days. Good clinical outcome was defined as modified Rankin Scale score of 0 to 2 at 90 days. Results- Twenty-five patients (50%) received IVT while the other 25 patients received EVT (50%) with or without IVT. Between these patient groups, there were no differences in age, sex, baseline National Institutes of Health Stroke Scale, interhospital transfer, or IVT rates. Thirty-two patients (64%) revascularized with 69% receiving EVT. There was a significant increase in median ADC value of the core lesion at 24 hours in patients who revascularized compared with further ADC reduction in nonrevascularization patients. Revascularization patients had a significantly higher rate of good clinical outcome at 90 days, 63% versus 9% (P=0.003). Core reversal at 24 hours was significantly higher in revascularization patients, 69% versus 22% (P=0.002). Conclusions- ADC evolution in acute ischemic stroke patients with early, complete revascularization, now more commonly seen with EVT, is strikingly different from our historical understanding. The early ADC normalization we have observed in this setting may include a component of secondary injury and serve as a potential imaging biomarker for the development of future adjunctive therapies. Clinical Trial Registration- URL: https://www.clinicaltrials.gov. Unique identifier: NCT00009243.
引用
- Hsia AW, Luby M, Cullison K, et al. Rapid Apparent Diffusion Coefficient Evolution After Early Revascularization. Stroke. 2019. PMID: 31238830. doi:10.1161/STROKEAHA.119.025784
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。